ASML CFO Says Trade War Worries Clients More Now Than in April
'Our customers are more concerned about the tariffs discussion today than they were three months ago,' Dassen said on a call with analysts Wednesday. 'Countries are in full battle mode again when it comes to tariffs.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Xebra Provides Update on MCTO
VANCOUVER, BC / / August 1, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTC PINK:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on July 2, 2025, in respect of the audited annual financial statements and corresponding management's discussion and analysis for the year ended February 28, 2025, including the CEO and CFO certifications (collectively, the "Annual Financial Filings") that were not filed by the required filing deadline of June 30, 2025 (the "Filing Deadline"). As previously disclosed, the Annual Financial Filings were not filed by the Filing Deadline due to the fact that there have been certain liquidity constraints and delays associated with recent changes of management. The Company is working expeditiously on the steps required to complete the Annual Financial Filings and expects to be able to file the Annual Financial Filings by August 29, 2025. The Company will provide updates as further information relating to the Annual Financial Filings becomes available. Until the Annual Financial Filings are filed, the MCTO will be in effect. Additionally, the Company will issue bi-weekly default status reports in accordance with National Policy 12-203 - Management Cease Trade Orders. The Company intends to satisfy the provisions of the Alternative Information Guidelines during the period it remains in default of the filing requirements. The Company confirms that there have been no material business developments or other material information relating to its affairs as of the date of this news release that have not been generally disclosed. ABOUT XEBRA BRANDS Brands is a Canadian cannabis company with international reach, focused on the development and commercialization of cannabis‑derived wellness products. Xebra is the first company to receive full authorization to import, cultivate, manufacture, and sell cannabis (‑1% THC) in Mexico, and is actively expanding its ELEMENTS™ product line through strategic partnerships in North America. On Behalf of Xebra Brands GallardoInterim CEO For more information contact:+52 55 6387 2293ir@ Forward-Looking InformationExcept for the statements of historical fact, this news release contains "forward-looking information" within the meaning of the applicable Canadian securities legislation that is based on expectations, estimates and projections as at the date of this news release. "Forward-looking information" in this news release includes, but is not limited to, business goals and objectives of the Company; statements and information regarding the timing for the filings of the Annual Filings; the Company's ability to be a first mover in a country, or to obtain or retain government licenses, permits, or authorizations in general, or specifically in Mexico, Canada or elsewhere, including cannabis authorizations from the Mexican Health Regulatory Agency (COFEPRIS); the Company's ability to satisfy the conditions of authorizations granted by COFEPRIS; any continuing uniqueness of any of the Company's products; and other forward-looking information concerning the intentions, plans and future actions of the parties to the transactions described herein and the terms thereon. Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to, the reliance of the Company on its auditors and management with respect to the Annual Filings; Such factors include, but are not limited to, the inability of the Company to retain the authorizations granted by COFEPRIS; the inability to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete potential acquisitions, dispositions or joint ventures for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; the timely receipt of regulatory approvals for license applications on terms satisfactory to the Company; and other related risks as more fully set out in the registration statement of Company and other documents disclosed under the Company's filings at In addition, there is no assurance that the Company will: be a low-cost producer or exporter; obtain a dominant market position in any jurisdiction; or have products that will be unique. The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about the Company's objectives, goals or future plans, the timing thereof and related matters. The Company has also assumed that no significant events occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein. SOURCE: Xebra Brands Ltd View the original press release on ACCESS Newswire
CNN
36 minutes ago
- CNN
Tariffs, Fed Vote, Jobs & More: Major Week For U.S. Economy - The Lead with Jake Tapper - Podcast on CNN Podcasts
Tariffs, Fed Vote, Jobs & More: Major Week For U.S. Economy The Lead with Jake Tapper 84 mins President Trump announces a slew of new tariffs. Also, President Trump deploys two nuclear submarines after what he calls provocative statements by Russia's former leader. Plus, a look at what CNN is learning about the transfer of Ghislaine Maxwell to a prison in Texas.
Yahoo
39 minutes ago
- Yahoo
Chelsea's Xavi Simons deal in danger! RB Leipzig refusing to take back Blues outcasts in deal as talks continue for Dutch forward
Chelsea's swap deal for Simons hits major roadblock RB Leipzig demand £60m — reject all swap offers Agent Ali Barat working to unlock transfer breakthrough Follow GOAL on WhatsApp! 🟢📱 WHAT HAPPENED? As per The Sun, Chelsea have offered multiple players in exchange for Simons, including Armando Broja and Carney Chukwuemeka. However, RB Leipzig are only interested in a cash deal worth £60m ($79m) for the Dutch international. Agent Ali Barat, who has good relations with Chelsea, is said to be working behind the scenes to try and rescue the transfer. THE BIGGER PICTURE Simons joined RB Leipzig permanently from Paris Saint-Germain in January after a loan stint with the Bundesliga side. His decision to leave comes after Leipzig failed to secure Champions League qualification. Chelsea, meanwhile, are making other moves in the market, sending Kendry Paez, Mike Penders, and Marc Guiu out on loan to open up the budget to sign Simons. DID YOU KNOW? RB Leipzig paid a club-record £43m for Simons, with add-ons potentially raising the deal to £70m. As such, Die Roten Bullen are not ready to sell the Dutchman for less than £60m. The Blues still view Simons as a priority target for the summer, despite the recent setback. WHAT NEXT FOR SIMONS? Negotiations are expected to continue as Chelsea weigh up whether to meet RB Leipzig's asking price for Simons. The Blues could return with a fresh offer later in the window if Barat finds a breakthrough. Meanwhile, other midfield options may be explored as a backup plan.
